Potential impact of myocardial perfusion scintigraphy as gatekeeper for invasive examination and treatment in patients with stable angina pectoris : observational study without post-test referral bias
AIMS: To evaluate the impact of using myocardial perfusion scintigraphy (MPS) as gatekeeper for coronary angiography and revascularization in stable angina pectoris.
METHODS AND RESULTS: A prospective series of 507 out of 972 adult patients referred to coronary angiography for known or suspected stable angina pectoris underwent clinical examination followed immediately by MPS, the result of which was not communicated. MPS showed normal perfusion in 258/507 (51%) patients, reversible defects in 201/507 (40%), and fixed defects in 48/507 (9%). Of 168 revascularized patients, 27 (16%) had normal perfusion and 13 (8%) had fixed defects. Coronary angiography was undertaken in 476 patients of whom 252 (53%) had normal findings or insignificant stenoses. The same was the case in 361 (41%) out of the 883 of the 972 consecutive patients, who had this examination. Assuming that the true rate of normal perfusion in the entire series was correspondingly lower, 48% of catheterizations and 19% of revascularizations were superfluous.
CONCLUSION: The use of MPS as gatekeeper appears to make about half of catheterizations and almost one-fifth of revascularizations redundant. Even in high-risk groups, substantial savings are possible, and the risk of overlooking patients with severe disease seems negligible.
Errataetall: | |
---|---|
Medienart: |
Artikel |
Erscheinungsjahr: |
2006 |
---|---|
Erschienen: |
2006 |
Enthalten in: |
Zur Gesamtaufnahme - volume:27 |
---|---|
Enthalten in: |
European heart journal - 27(2006), 1 vom: 15. Jan., Seite 29-34 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Høilund-Carlsen, Poul F [VerfasserIn] |
---|
Themen: |
971Z4W1S09 |
---|
Anmerkungen: |
Date Completed 20.07.2006 Date Revised 03.12.2018 published: Print-Electronic CommentIn: Eur Heart J. 2006 Jan;27(1):3-4. - PMID 16267072 Citation Status MEDLINE |
---|
Förderinstitution / Projekttitel: |
|
---|
PPN (Katalog-ID): |
NLM157966496 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM157966496 | ||
003 | DE-627 | ||
005 | 20231223081246.0 | ||
007 | tu | ||
008 | 231223s2006 xx ||||| 00| ||eng c | ||
028 | 5 | 2 | |a pubmed24n0527.xml |
035 | |a (DE-627)NLM157966496 | ||
035 | |a (NLM)16183689 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Høilund-Carlsen, Poul F |e verfasserin |4 aut | |
245 | 1 | 0 | |a Potential impact of myocardial perfusion scintigraphy as gatekeeper for invasive examination and treatment in patients with stable angina pectoris |b observational study without post-test referral bias |
264 | 1 | |c 2006 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ohne Hilfsmittel zu benutzen |b n |2 rdamedia | ||
338 | |a Band |b nc |2 rdacarrier | ||
500 | |a Date Completed 20.07.2006 | ||
500 | |a Date Revised 03.12.2018 | ||
500 | |a published: Print-Electronic | ||
500 | |a CommentIn: Eur Heart J. 2006 Jan;27(1):3-4. - PMID 16267072 | ||
500 | |a Citation Status MEDLINE | ||
520 | |a AIMS: To evaluate the impact of using myocardial perfusion scintigraphy (MPS) as gatekeeper for coronary angiography and revascularization in stable angina pectoris | ||
520 | |a METHODS AND RESULTS: A prospective series of 507 out of 972 adult patients referred to coronary angiography for known or suspected stable angina pectoris underwent clinical examination followed immediately by MPS, the result of which was not communicated. MPS showed normal perfusion in 258/507 (51%) patients, reversible defects in 201/507 (40%), and fixed defects in 48/507 (9%). Of 168 revascularized patients, 27 (16%) had normal perfusion and 13 (8%) had fixed defects. Coronary angiography was undertaken in 476 patients of whom 252 (53%) had normal findings or insignificant stenoses. The same was the case in 361 (41%) out of the 883 of the 972 consecutive patients, who had this examination. Assuming that the true rate of normal perfusion in the entire series was correspondingly lower, 48% of catheterizations and 19% of revascularizations were superfluous | ||
520 | |a CONCLUSION: The use of MPS as gatekeeper appears to make about half of catheterizations and almost one-fifth of revascularizations redundant. Even in high-risk groups, substantial savings are possible, and the risk of overlooking patients with severe disease seems negligible | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Research Support, Non-U.S. Gov't | |
650 | 7 | |a Radiopharmaceuticals |2 NLM | |
650 | 7 | |a Technetium Tc 99m Sestamibi |2 NLM | |
650 | 7 | |a 971Z4W1S09 |2 NLM | |
700 | 1 | |a Johansen, Allan |e verfasserin |4 aut | |
700 | 1 | |a Christensen, Henrik Wulff |e verfasserin |4 aut | |
700 | 1 | |a Vach, Werner |e verfasserin |4 aut | |
700 | 1 | |a Møldrup, Mette |e verfasserin |4 aut | |
700 | 1 | |a Bartram, Peter |e verfasserin |4 aut | |
700 | 1 | |a Veje, Annegrete |e verfasserin |4 aut | |
700 | 1 | |a Haghfelt, Torben |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t European heart journal |d 1983 |g 27(2006), 1 vom: 15. Jan., Seite 29-34 |w (DE-627)NLM012617253 |x 1522-9645 |7 nnns |
773 | 1 | 8 | |g volume:27 |g year:2006 |g number:1 |g day:15 |g month:01 |g pages:29-34 |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 27 |j 2006 |e 1 |b 15 |c 01 |h 29-34 |